Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × niraparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 9 Neoplasms 4 Neoplasm Metastasis 4 Fallopian Tube Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Prostatic Neoplasms, Castration-Resistant 2 Pancreatic Neoplasms 2 Glioma 2 Glioblastoma 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-sensitive Prostate Cancer 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Endometrial Neoplasms 1 Disease Progression 1 Central Nervous System Neoplasms 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 trametinib 1 selpercatinib 1 selinexor 1 ribociclib 1 repotrectinib 1 relatlimab 1 relacorilant 1 pralsetinib 1 palbociclib 1 olaparib 1 exemestane 1 elacestrant 1 darolutamide 1 dabrafenib 1 ceralasertib 1 abemaciclib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Sunitinib 1 STX-478 1 Radiosurgery 1 RAD1901 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡